Kaveri Puldman
Analyst
Clear Street
Equibles does not estimate personal net worth.
About Kaveri Puldman
Kaveri Puldman is recorded as Analyst at Clear Street. Kaveri Puldman has spoken on 1 earnings call across 1 company, most recently for Trevi Therapeutics, Inc. on May 5, 2026. The companies whose calls Kaveri Puldman spoke on are classified in the Healthcare sector.
Kaveri Puldman on recent calls
“Just to like a follow-up on the previous comments you made on the Phase 2B RCC trial design, I was wondering how you were thinking about enrolling a truly addressable patient population to fully de-risk the program, particularly given the expectations that many patients may be P2X3 antagonist experience in real world.”
Affiliation history
-
Clear Street
Analyst
Transcript header (unverified)
Current